Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum…
Genelux Corporation announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for the development program of Olvi-Vec (olvimulogene…
Read More...
Read More...
